Detalhe da pesquisa
1.
Insertional mutagenesis and deep profiling reveals gene hierarchies and a Myc/p53-dependent bottleneck in lymphomagenesis.
PLoS Genet
; 10(2): e1004167, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24586197
2.
Development and Characterisation of a New Patient-Derived Xenograft Model of AR-Negative Metastatic Castration-Resistant Prostate Cancer.
Cells
; 13(8)2024 Apr 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38667288
3.
Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.
Nat Genet
; 56(3): 458-472, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38351382
4.
A simple, sensitive and selective quantum-dot-based western blot method for the simultaneous detection of multiple targets from cell lysates.
Anal Bioanal Chem
; 398(1): 547-54, 2010 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-20582696
5.
Author Correction: Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.
Nat Genet
; 56(6): 1321, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38831011
6.
mAMSA resistant human topoisomerase IIbeta mutation G465D has reduced ATP hydrolysis activity.
Nucleic Acids Res
; 34(5): 1597-607, 2006.
Artigo
Inglês
| MEDLINE | ID: mdl-16549872
7.
Gamma-Retrovirus Integration Marks Cell Type-Specific Cancer Genes: A Novel Profiling Tool in Cancer Genomics.
PLoS One
; 11(4): e0154070, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27097319
8.
The impact of the C-terminal domain on the interaction of human DNA topoisomerase II α and ß with DNA.
PLoS One
; 6(2): e14693, 2011 Feb 16.
Artigo
Inglês
| MEDLINE | ID: mdl-21358820
9.
The impact of the human DNA topoisomerase II C-terminal domain on activity.
PLoS One
; 3(3): e1754, 2008 Mar 12.
Artigo
Inglês
| MEDLINE | ID: mdl-18335031
10.
Curcumin induces high levels of topoisomerase I- and II-DNA complexes in K562 leukemia cells.
J Nat Prod
; 70(12): 1884-8, 2007 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-18076140
11.
Differential selection of acridine resistance mutations in human DNA topoisomerase IIbeta is dependent on the acridine structure.
Mol Pharmacol
; 71(4): 1006-14, 2007 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-17209120